Statement of House Representatives Smith, Hartzler, and Walker on the FDA Canceling Its Contract with Advanced Bioscience Resources
Statement from the Department of Health and Human Services
“After a recent review of a contract between Advanced Bioscience Resources, Inc. and the Food and Drug Administration to provide human fetal tissue to develop testing protocols, HHS was not sufficiently assured that the contract included the appropriate protections applicable to fetal tissue research or met all other procurement requirements. As a result, that contract has been terminated, and HHS is now conducting an audit of all acquisitions involving human fetal tissue to ensure conformity with procurement and human fetal tissue research laws and regulations. In addition, HHS has initiated a comprehensive review of all research involving fetal tissue to ensure consistency with statutes and regulations governing such research, and to ensure the adequacy of procedures and oversight of this research in light of the serious regulatory, moral, and ethical considerations involved. Finally, HHS is continuing to review whether adequate alternatives exist to the use of human fetal tissue in HHS funded research and will ensure that efforts to develop such alternatives are funded and accelerated.”
FOR IMMEDIATE RELEASE Contact: Smith- Matt Hadro (202) 225-3765
September 26, 2018 Hartzler- Anna Swick (202) 225-2876
Walker- Alexei Woltornist (202) 734-2253
Statement of Smith, Hartzler, and Walker on the FDA Canceling Its Contract with Advanced Bioscience Resources
WASHINGTON, DC— Reps. Chris Smith (R-NJ-04), Vicky Hartzler (R-MO-04) and Mark Walker (R-NC-06), who led a letter from 85 Members of Congress to the Commissioner of the Food and Drug Administration (FDA) Scott Gottlieb, urging him to cancel the FDA’s contract with Advanced Bioscience Resources (ABR), released the following statement on Wednesday:
“We commend the Department of Health and Human Services (HHS) for canceling the FDA’s most recent contract with the discredited company, Advanced Bioscience Resources, for research using body parts of aborted babies. In our letter to the FDA, dated September 17, we urged the Department to not only cancel that particular contract but to utilize modern scientific techniques that do not contribute to trafficking in baby body parts. We remain deeply concerned that aborted fetal tissue may continue to be used in the FDA’s ongoing research efforts unless more clear guardrails are put in place by the Department.
“Further, the fact remains that this barbaric research is annually supported by about $100 million in funding from the National Institutes of Health (NIH).
“Therefore, we urge Secretary Azar to immediately issue a complete HHS-wide moratorium of aborted fetal tissue research that treats babies like test subjects.
“The practice of conducting research using the body parts of children whose lives have been violently ended by abortion is abhorrent. Ethical alternatives exist and must be employed.”